On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients
- 28 May 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (11) , 5501-5511
Abstract
Cystic fibrosis (CF) is a disease of dysregulated salt and fluid homeostasis that results in massive accumulation of neutrophil elastase resulting in lung degradation and death. The current CF therapy relies on inhaled deoxyribonuclease and hypertonic saline, but does not address elastolytic degradation of the lung. We reasoned that allosteric agents targeting the heparin-binding site of neutrophil elastase would offer a therapeutic paradigm. Screening a library of 60 non-saccharide glycosaminoglycan mimetics (NSGMs) led to discovery of 23 hits against neutrophil elastase. To identify a lead NSGM that works in sync with the current CF relieving agents, we developed a rigorous protocol based on fundamental computational, biochemical, mechanistic, and adverse effects studies. The lead NSGM so identified neutralized neutrophil elastase present in the sputum of CF patients in the presence of deoxyribonuclease and high salt conditions. Our work presents the process for discovering potent, small, synthetic, allosteric, anti-CF agents, while also identifying a novel lead for further studies in animal models of CF.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (P01 HL107152, R01 HL090586, K12 HL141954, HL128639)
- Cystic Fibrosis Foundation (Voynow1510)
- Virginia Commonwealth Health Research Board
This publication has 49 references indexed in Scilit:
- Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammationPulmonary Pharmacology & Therapeutics, 2013
- Disease phenotype of a ferret CFTR-knockout model of cystic fibrosisJournal of Clinical Investigation, 2010
- Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory responseJournal of Molecular Medicine, 2010
- Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteasesProtein Science, 2009
- Proteases and cystic fibrosisThe International Journal of Biochemistry & Cell Biology, 2008
- Production of CFTR-null and CFTR-ΔF508 heterozygous pigs by adeno-associated virus–mediated gene targeting and somatic cell nuclear transferJournal of Clinical Investigation, 2008
- Targeting neutrophil elastase in cystic fibrosisExpert Opinion on Therapeutic Targets, 2008
- New Insights into the Inhibition of Human Neutrophil Elastase by HeparinBiochemistry, 2006
- Inhibition of human leukocyte elastase activity by heparins: influence of charge densityBiochimica et Biophysica Acta (BBA) - General Subjects, 1996
- Interaction between human leukocyte elastase and chondroitin sulfateChemico-Biological Interactions, 1984